Creoptix
Company Details
Status: Private
Employees: 1,001-10,000
Location:
Wädenswil, Switzerland
Type:
sample
Technology:
About: CREOPTIX IS NOW A MALVERN PANALYTICAL PHARMACEUTICALS BRAND.
Please follow us on this page to stay up to date > https://lnkd.in/e_UMrvip
THE WAVE OF THE FUTURE IN KINETICS.
Experience a new level of performance and flexibility in drug discovery.
By bringing together modern label-free technology, application development know-how and sophisticated software, Creoptix offers a unique optical biosensor tool for binding kinetics. Engineered around our proprietary Grating-Coupled Interferometry (GCI) technology, the Creoptix WAVEsystem delivers high-quality kinetic data across a broader range of samples than traditional SPR equipment.
Following integration in January 2022, Creoptix is a Malvern Panalytical brand.
About Malvern Panalytical:
We draw on the power of our analytical instruments and services to make the invisible visible and the impossible possible.
Through the chemical, physical and structural analysis of materials, our high precision analytical systems and top-notch services support our customers in creating a better world. We help them improve everything from the energies that power us and the materials we build with, to the medicines that cure us and the foods we enjoy.
With over 2300 employees, we serve the world, and we are part of Spectris plc, the world leading precision measurement group. Malvern Panalytical. We're BIG on small™
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Creoptix | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.